| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000016783 |
| Receipt No. | R000019471 |
| Official scientific title of the study | Study of treatment starategy for patients with castration resistsnt prostate cancer using new hormonal agents before chemotherapy |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2018/09/12 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study of treatment starategy for patients with castration resistsnt prostate cancer using new hormonal agents before chemotherapy | |
| Title of the study (Brief title) | Starategy for pre-chemo CRPC | |
| Region |
|
|
| Condition | ||
| Condition | Prostate cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To know impact of new hormonal agents (Enzalutamide and abiraterone) in patients with castration resistant prostate cancer before chemotherapy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | PSA resopnse |
| Key secondary outcomes | QOL
Duration before chemotherapy Skeletal related event Survival |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1. Pathologicalyconfirmation of prostate cancer
2. Castration resistant prostate cancer 3. Next treatment: Enzalutamide or abiraterone 4. No chemotherapy 5. No steroids 6. Performance status 0-1 |
|||
| Key exclusion criteria | 1. Other malignancies
2. Prior chemotherapy (excluding estramuscin) 3. Steroids 4. Severe visceral dysfunction 5. Other clinical trial 6. Prior enzalutamide or abiraterone |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Mitsuzuka Koji |
| Organization | Tohoku University School of Medicine |
| Division name | Urology |
| Address | 1-1 Seiryo-machi,Aoba-ku, Sendai, Miyagi 980-8574, Japan |
| TEL | 022-717-7278 |
| yarai@uro.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Mitsuzuka Koji |
| Organization | Tohoku University School of Medicine |
| Division name | Urology |
| Address | 1-1 Seiryo-machi,Aoba-ku, Sendai, Miyagi 980-8574, Japan |
| TEL | 022-717-7278 |
| Homepage URL | |
| mitsuzuka@uro.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of urology, Tohoku University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Astellas |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Clinical ressearch, Innovation and Education Center, Tohoku University Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 弘前大学(青森県)、秋田大学(秋田県)、宮城県立がんセンター(宮城県)、むつ総合病院(青森県)、青森県立中央病院(青森県)、青森労災病院(青森県)、八戸市民病院(青森県)、秋田赤十字病院(秋田県)、市立秋田総合病院(秋田県)、大館市立病院(秋田県)、岩手県立磐井病院(岩手県)、栗原中央病院(宮城県)、気仙沼市立病院(宮城県)、大崎市民病院(宮城県)、仙台医療センター(宮城県)、宮城県立がんセンター(宮城県)、仙台市立病院(宮城県)、柳生クリニック(宮城県)、東北公済病院(宮城県)、泉中央病院(宮城県)、仙塩利府病院(宮城県)、山形県立中央病院(宮城県)、白河厚生総合病院(福島県)、総合磐城共立病院(福島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective observation study
Efficiency of each drugs Setquential effiiency among the drugs |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019471 |